Abstract
Evidence accumulates that airway mucins harbour disease-related alterations in their composition and glycosylation. For cystic fibrosis patients a correlation between the severity of airway infections and an increase in mucin sialylation was described. A similar change in glycosylation was observed upon the induction of asthma in experimental animals. In case of COPD the ratio of the two major airway mucins MUC5AC and MUC5B was reported to differ from that in healthy individuals. This opens the possibility to diagnose and monitor inflammatory airway disorders based on the composition and glycosylation of the mucin from patient samples.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
